Skip to main content
Figure 1 | BMC Pharmacology

Figure 1

From: Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats

Figure 1

Efeects of PPARγ agonist GI262570 on serum adiponectin level (a), adipose FABP3 mRNA level (b), and the correlation between serum adiponectin and adipose FABP3 mRNA. SD rats were on HF diet for 4 weeks. GI262570 was oral dosed for the later 2 weeks. Mean ± SEM. N = 5–8 in each group. *p < 0.05 vs vehicle. **p < 0.01 vs vehicle.

Back to article page